disease-free survival

Explore academic connections and research related to this keyword

258
Views
15
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
Chiappella A;Martelli M;Angelucci E;Brusamolino E;Evangelista A;Carella AM;Stelitano C;Rossi G;Balza...
2017 the lancet oncology 403 views
2
Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Gagelmann N;Eikema DJ;Koster L;Caillot D;Pioltelli P;Lleonart JB;Reményi P;Blaise D;Schaap N;Trneny...
2019 biology of blood and marrow transplantation : jour... 346 views
3
Lymph node micrometastases and outcome of endometrial cancer
Ignatov A;Lebius C;Ignatov T;Ivros S;Knueppel R;Papathemelis T;Ortmann O;Eggemann H;;
2019 gynecologic oncology 297 views
4
Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer
Shin SH;Park Y;Hwang DW;Song KB;Lee JH;Kwon J;Yoo C;Alshammary S;Kim SC;;
2019 Anticancer research 346 views
5
Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group
Kogawa K;Sato H;Asano T;Ohga S;Kudo K;Morimoto A;Ohta S;Wakiguchi H;Kanegane H;Oda M;Ishii E;;
2014 pediatric blood & cancer 428 views
6
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments
Bari A;Marcheselli R;Sacchi S;Re A;Pagani C;Tucci A;Botto B;Vitolo U;Molinari AL;Puccini B;Pulsoni A...
2020 Annals of hematology 260 views
7
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)
Rowe JM;Andersen JW;Mazza JJ;Bennett JM;Paietta E;Hayes FA;Oette D;Cassileth PA;Stadtmauer EA;Wierni...
1995 Blood 341 views
8
Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial
Altenberger J;Parissis JT;Costard-Jaeckle A;Winter A;Ebner C;Karavidas A;Sihorsch K;Avgeropoulou E;W...
2014 european journal of heart failure 300 views
9
Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas
Inoue K;Zindy F;Randle DH;Rehg JE;Sherr CJ;;
2001 genes & development 335 views
10
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
Palumbo A;Hajek R;Delforge M;Kropff M;Petrucci MT;Catalano J;Gisslinger H;Wiktor-Jędrzejczak W;Zodel...
2012 The New England journal of medicine 344 views
11
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
Palumbo A;Bringhen S;Caravita T;Merla E;Capparella V;Callea V;Cangialosi C;Grasso M;Rossini F;Galli...
2006 Lancet (London, England) 240 views
12
Saccharomyces cerevisiae infections in children
Fiore NF;Conway JH;West KW;Kleiman MB;;
1998 the pediatric infectious disease journal 184 views
13
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
Gay F;Oliva S;Petrucci MT;Conticello C;Catalano L;Corradini P;Siniscalchi A;Magarotto V;Pour L;Carel...
2015 The Lancet. Oncology 254 views
14
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Cavo M;Gay F;Beksac M;Pantani L;Petrucci MT;Dimopoulos MA;Dozza L;van der Holt B;Zweegman S;Oliva S;...
2020 The Lancet. Haematology 330 views
15
Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas
Kazushi Inoue, Frederique Zindy, David H. Randle, Jerold E. Rehg, Charles J. Sherr;Kazushi Inoue;Fre...
2001 genes & development DOI: 10.1101/gad.929901 164 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

transplantation National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male middle aged Comparative Study risk factors Clinical Trial Phase III